AlphaTON Capital Corp. (NASDAQ:ATON) shares are trading higher Wednesday after the company announced a letter of intent to evaluate tokenization of single-indication economics for TT-4 in mesothelioma.
AlphaTON Capital Corp (NASDAQ:ATON) shares surged in after-hours trading on Tuesday, jumping 123.12% from the regular session close of $5.58 to $12.45. This $6.87 rise more than doubled the stock's price after the market closed.
